Acute Coronary SyndromeMatador-PCINCT03656523
Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
An observational study of Acute Coronary Syndrome and Atrial Fibrillation, run by Heart Care Foundation at 76 sites in Italy.
Trial summary
ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS. Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Acute Coronary Syndrome, Atrial Fibrillation
- What is being tested?
- Acute coronary syndrome and PCI and AF
- How many people
- 598 participants
- Where
- 76 sitesItaly
- Study dates
- 25 Jul 2018to 17 Aug 2020
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Patients with ACS trated with PCI with stent implantation developing or having Atrial Fibrillation.
Who may be able to join
- All consecutive ACS patients treated with PCI with stent implantation who present AF at admission or during hospital stay, before or after stent implantation.
Who cannot join
- Patients admitted with a diagnosis of ACS at the time of enrolment but not confirmed during hospitalization
- ACS treated medically or with PCI but without stent implantation
- Patients not giving informed consent
Trial locations and contacts
76 sites in 1 country.
76 sites in 1 country
Italy76 sites
Osp. Andria Canosa - Po Andria - Cardiologia - Utic
Andria, BT, 76123
Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti'
Avellino, AV, 83100
Presidio Ospedaliero Moscati - U.O.C. Cardiologia
Aversa, CE, 81031
Ospedale Civile Ss. Filippo E Nicola - U.O. Cardiologia E Utic
Avezzano, AQ, 67051
Ospedale Di Venere - U.O.C. Di Cardiologia
Bari, BA, 70012
Ospedale San Paolo - Cardiologia-Utic
Bari, BA, 70123
Ospedale Policlinico - U.O. Cardiologia Universitaria
Bari, BA, 70124
Ospedale Civile - Sc Cardiologia
Belluno, BL, 32100
Azienda Ospedaliera G. Rummo - Cardiologia Interventistica E Utic
Benevento, BD, 82100
Ospedale Maggiore - U.O. Di Cardiologia
Bologna, BO, 40133
Ospedale Perrino - U.O.C. Di Cardiologia
Brindisi, BR, 72100
Azienda Ospedaliera G. Brotzu - Struttura Complessa Di Cardiologia
Cagliari, CA, 09134
Az. Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia-Utic
Caserta, CE, 81100
Pineta Grande Hospital - Unita Terapia Intensiva Coronarica
Castel Volturno, CE, 81030
Azienda Ospedaliera Cannizzaro - Uoc Cardiologia Con Utic Ed Emodinamica
Catania, CT, 95126
Fondazione G. Giglio - U.O. Cardiologia E Utic
Cefalù, PA, 90015
Ospedale Santa Maria Dei Battuti - U.O. Di Cardiologia
Conegliano, TV, 31015
Ospedale Di Circolo Di Desio - U.O.C. Di Cardiologia-Utic
Desio, MB, 20832
Ospedale Maria Ss. Addolorata - U.O. Di Cardiologia Utic
Eboli, SA, 84025
Ospedale San Giovanni Di Dio - Cardiologia
Florence, FI, 50124
Ospedali Riuniti - S.C. Di Cardiologia Univ.-Utic
Foggia, FG, 71100
Nuovo Ospedale San Giovanni Battista - S.C. Cardiologia
Foligno, PG, 06034
Ospedale G.B. Morgagni - L. Pierantoni - U.O. Cardiologia
Forlì, FC, 47100
E.O. Ospedali Galliera - S. C. Cardiologia
Genova, GE, 16128
Ospedale Moriggia Pelascini - Unita' Operativa Di Cardiologia
Gravedona, CO, 22015
Ospedale Nuovo S. Maria Della Scaletta - Uoc Cardiologia
Imola, BO, 40026
Ospedale Vito Fazzi - U.O. Di Cardiologia
Lecce, LE, 73100
Ospedale Civile - Uo Cardiologia
Legnano, MI, 20025
Nuovo Ospedale Versilia - Sc Cardiologia
Lido di Camaiore, LU, 55043
Ospedale Civile Fornaroli - U.O. Cardiologia
Magenta, MI, 20013
Ospedale San Leopoldo Mandic - Cardiologia - Ucc
Merate, LC, 23807
Centro Cardiologico Monzino - Terapia Intensiva Cardiologica (Utic)
Milan, MI, 20138
Ospedale San Paolo - Uo Cardiologia E Utic
Milan, MI, 20142
Ospedale San Luca - Istituto Auxologico - U.O. Cardiologia
Milan, MI, 20149
Ospedale San Carlo Borromeo - Cardiologia-Ucc
Milan, MI, 20153
Asst Ospedale Metropolitano Niguarda - Cardiologia 1 - Emodinamica
Milan, MI, 20162
Ospedale Civile - U.O. Cardiologia
Mirano, VE, 30035
Aorn Cardarelli - U.O. Cardiologia Con Utic
Naples, 80131
Ospedale Del Mare - U.O. Cardiologia Con Utic
Naples, 80142
Pres. Ospedaliero S. Maria Della Pieta' - U.O. Cardiologia E Utic
Nola, 80035
Ospedale San Francesco - Cardiologia - Utic
Nuoro, NU, 08100
Ospedale San Luigi Gonzaga - S.C.D.O. Cardiologia
Orbassano, TO, 10043
Aor Villa Sofia-Cervello P.O. Cervello - U.O. Cardiologia - Cervello
Palermo, PA, 90146
Fondazione Irccs Policlinico San Matteo - Card. Con Ucc-Lab. Ricerca Sperim. Card.
Pavia, PV, 27100
Presidio Ospedaliero San Salvatore - Cardiologia E Utic
Pesaro, PU, 61121
Casa Di Cura Dr. Pederzoli - Servizio Di Cardiologia
Peschiera del Garda, VR, 37019
Ospedale Della Val Di Nievole - U. O. Cardiologia - Utic
Pescia, Point, 51017
Ospedale San Jacopo - U.O. Cardiologia
Pistoia, Point, 51100
Ospedale Di Pordenone - S.O.C. Cardiologia
Pordenone, PN, 33170
Azienda Ospedaliera San Carlo - Ssd Utic
Potenza, PZ, 85100
Ospedale M.P. Arezzo - U.O.C. Cardiologia-Utic
Ragusa, RG, 97100
Ao Bianchi Melacrino Morelli- Po Riuniti - Divisione Di Cardiologia
Reggio Calabria, RC, 89124
Arcispedale Santa Maria Nuova - S.C. Cardiologia
Reggio Emilia, RE, 42100
Ospedale Civile - Unita' Operativa Di Cardiologia
Rho, MI, 20017
Ospedale Degli Infermi - Sc Cardiologia
Rivoli, TO, 10098
P.O. San Filippo Neri - Asl Roma 1 - Uoc Cardiologia E Utic
Roma, RM, 00135
Ospedale San Camillo - Uoc Cardiologia 1
Roma, RM, 00152
Policlinico Umberto Primo - Cardiologia B - Cardiologia E Angiologia
Roma, RM, 00161
Ospedale Sant'Andrea Di Roma - U.O.C. Cardiologia
Roma, RM, 00189
Ospedale Santo Spirito - U.O.C. Di Cardiologia
Roma, RM, 00193
Ospedale Santa Maria Del Carmine - Cardiologia
Rovereto, TN, 38068
Ospedale Civile - U.O. Cardiologia
San Donà di Piave, VE, 30027
Presidio Ospedaliero T. Masselli Mascia - S.C. Cardiologia - Utic - Riabil. Card.
San Severo, FG, 71016
Ospedale San Giuseppe E Melorio - U.O.C. Cardiologia Utic
Santa Maria Capua Vetere, CE, 81055
Ospedale Di Sassuolo - Cardiologia
Sassuolo, MO, 41049
Ospedale San Paolo - U.O. Di Cardiologia
Savona, SV, 17100
Azienda Ospedaliera Santa Maria - S.C. Di Cardiologia
Terni, TR, 05100
Ospedale San Giovanni Evangelista - U.O.C. Di Cardiologia - Utic
Tivoli, RM, 00019
Ospedale Maria Vittoria - U.O. Cardiologia
Torino, TO, 10149
Ospedale Giovanni Bosco - Sc Cardiologia
Torino, TO, 10155
Ospedale Santa Chiara - Ospedale Santa Chiara
Trento, TN, 38122
Ospedali Treviglio-Caravaggio - Cardiologia
Treviglio, BG, 24047
Azienda Osp. Cardinale G. Panico - U.O. Cardiologia - Utic
Tricase, LE, 73039
Pou Santa Maria Della Misericordia - S.O.C. Cardiologia
Udine, UD, 33100
Ospedale Di Circolo E Fondazione Macchi - Ssd Unita' Di Cure Intensive Coronariche
Varese, VA, 21100
Ospedale Belcolle - U.O.C. Cardiologia Utic Emodinamica
Viterbo, VT, 01100
About this study
ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS.
Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear
Read the detailed description
There are limited data available, particularly from a representative population-based perspective describing recent pharmacological and non-pharmacological management and clinical event rates associated with AF complicating ACS in the era of novel treatment strategies (in both AF and ACS) and high coronary reperfusion rates.
This registry will assess the current in-hospital management and clinical events at 6 months of consecutive patients admitted in Italian cardiology intensive care units (CCUs) for an ACS treated invasively with PCI and stent implantation who present AF at admission or during hospital stay, before or after stent implantation .
- Conditions
- Acute Coronary Syndrome, Atrial Fibrillation
- Being tested
- Acute coronary syndrome and PCI and AF
- Keywords
- Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention
- Medical subject headings
- Acute Coronary Syndrome, Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Acute coronary syndrome and PCI and AFOther
Patient with ACS and ACS treated with PCI
| Study group | Role | What they receive |
|---|---|---|
| Acute Coronary Syndrome | Patients with Aute coronary syndrome trated with Percutaneous Coronary Intervention plus Stent implantation and Atrial Fibrillation Receives: Other: Acute coronary syndrome and PCI and AF |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical epidemiology
Demographics
Measured: Enrollement
Management
Pharmacological treatment
Measured: 6 months
Antithrombotic strategy
Intravenous or oral antiplatelet and anticoagulation therapies and their combination
Measured: 6 months
Clinical epidemiology
Clinical history
Measured: Enrollement
Clinical epidemiology
Type of AF
Measured: Enrollement
Clinical epidemiology
Type of ACS
Measured: Enrollement
Management
Time of PCI
Measured: 6 months
Number of procedure performed on enrolled patients
In-hospital management
Measured: 6 months
Secondary outcomes (2)
Pharmacological therapies
Use and persistence of therapies prescribed at discharge
Measured: 6 months
Clinical outcomes
All cause deaths, major bleedings, non fatal stroke, systemic embolism, transiet ischemic attach, MI recurrence
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Sep 2018
- Study start25 Jul 2018
- Primary completion17 Aug 2020
- Study completion17 Aug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Acute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 598 participants (actual)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Heart Care Foundation
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03656523
- Sponsor's protocol ID
- K20
- Acronym
- Matador-PCI
- Status last verified
- Oct 2020
- First submitted
- 9 Aug 2018
- Last updated
- 3 Feb 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
De Luca L, Bolognese L, Rubboli A, Vetrano A, Callerame M, Rivetti L, Gonzini L, Gabrielli D, Di Lenarda A, Gulizia MM; MATADOR-PCI Investigators. Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e45-e47. doi: 10.1093/ehjcvp/pvaa088. No abstract available.
PubMed 32651996De Luca L, Rubboli A, Bolognese L, Gonzini L, Urbinati S, Murrone A, Scotto di Uccio F, Ferrari F, Luca F, Caldarola P, Lucci D, Gabrielli D, Di Lenarda A, Gulizia MM; MATADOR-PCI Investigators. Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study. BMJ Open. 2020 Dec 22;10(12):e041044. doi: 10.1136/bmjopen-2020-041044.
PubMed 33371033
Study at a glance
From the registry record, last updated by the sponsor on 3 Feb 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI
- ClinicalTrials.gov ID
- NCT03656523
- Acronym / sponsor ID
- Matador-PCI / K20
- Conditions
- Acute Coronary Syndrome, Atrial Fibrillation
- Keywords
- Acute Coronary Syndrome, Atrial Fibrillation, Percutaneous Coronary Intervention
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 598 participants (actual)
- Lead sponsor
- Heart Care FoundationUniversity, hospital or other
- Study start
- 25 Jul 2018 (actual)
- Primary completion
- 17 Aug 2020 (actual)
- Study completion
- 17 Aug 2020 (actual)
- First posted
- 4 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ACS are a potent risk factor for AF, with new onset AF occurring in up to 1 in every 5 patients hospitalized with an ACS.
Despite its relatively frequent occurrence and the many etiologic factors involved in its pathogenetic condition, the frequency and prognostic significance of AF complicating ACS remain unclear
Detailed description
There are limited data available, particularly from a representative population-based perspective describing recent pharmacological and non-pharmacological management and clinical event rates associated with AF complicating ACS in the era of novel treatment strategies (in both AF and ACS) and high coronary reperfusion rates.
This registry will assess the current in-hospital management and clinical events at 6 months of consecutive patients admitted in Italian cardiology intensive care units (CCUs) for an ACS treated invasively with PCI and stent implantation who present AF at admission or during hospital stay, before or after stent implantation .
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 6 Months
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Acute Coronary Syndrome | – | Other: Acute coronary syndrome and PCI and AFPatients with Aute coronary syndrome trated with Percutaneous Coronary Intervention plus Stent implantation and Atrial Fibrillation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients with ACS trated with PCI with stent implantation developing or having Atrial Fibrillation.
Key inclusion criteria (1 listed)
- All consecutive ACS patients treated with PCI with stent implantation who present AF at admission or during hospital stay, before or after stent implantation.
Key exclusion criteria (3 listed)
- Patients admitted with a diagnosis of ACS at the time of enrolment but not confirmed during hospitalization
- ACS treated medically or with PCI but without stent implantation
- Patients not giving informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Acute coronary syndrome and PCI and AFPatient with ACS and ACS treated with PCI | Other | Acute Coronary Syndrome |
Primary outcome
Clinical epidemiology
Time frame: Enrollement
Demographics
Management
Time frame: 6 months
Pharmacological treatment
Antithrombotic strategy
Time frame: 6 months
Intravenous or oral antiplatelet and anticoagulation therapies and their combination
Clinical epidemiology
Time frame: Enrollement
Clinical history
Clinical epidemiology
Time frame: Enrollement
Type of AF
Clinical epidemiology
Time frame: Enrollement
Type of ACS
Management
Time frame: 6 months
Time of PCI
Number of procedure performed on enrolled patients
Time frame: 6 months
In-hospital management
2 secondary outcomes
Pharmacological therapies
Time frame: 6 months
Clinical outcomes
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Feb 2021.
- Background: PubMed 32651996De Luca L, Bolognese L, Rubboli A, Vetrano A, Callerame M, Rivetti L, Gonzini L, Gabrielli D, Di Lenarda A, Gulizia MM; MATADOR-PCI Investigators. Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):e45-e47. doi: 10.1093/ehjcvp/pvaa088. No abstract available.
- Results publication: PubMed 33371033De Luca L, Rubboli A, Bolognese L, Gonzini L, Urbinati S, Murrone A, Scotto di Uccio F, Ferrari F, Luca F, Caldarola P, Lucci D, Gabrielli D, Di Lenarda A, Gulizia MM; MATADOR-PCI Investigators. Antithrombotic management of patients with acute coronary syndrome and atrial fibrillation undergoing coronary stenting: a prospective, observational, nationwide study. BMJ Open. 2020 Dec 22;10(12):e041044. doi: 10.1136/bmjopen-2020-041044.
- Individual participant dataSharing planned: No
Related trials for Acute Coronary Syndrome
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
76 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Acute Coronary Syndrome and Atrial Fibrillation, run by Heart Care Foundation at 76 sites in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 76 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical epidemiology (time frame: Enrollement). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03656523, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2021.